MOMETASONE FUROATE USP 1GM by Letco Medical Safety Data Sheet Section 1: Identification Common Name/Trade Name Mometasone Furoate USP Supplier Information Letco Medical, LLC 1316 Commerce Drive NW Decatur, AL 35601 1 (800) 239-5288 +1 (734) 843-4693 IN CASE OF EMERGENCY: Chemtrec 1 (800) 424-9300 (24 hours) Product Synonym(s) N/A Relevant Use(s) of Product Manuf acture or Compounding of Substances Section 2: Hazards Identification Classification of Substance or Mixture Reproductive toxicity Category 2. Specif ic target organ toxicity, repeated exposure Category 1 (endochrine system). Signal Word Danger Hazard Statement(s) H361 Suspected of damaging f ertility or the unborn child H372 Causes damage to organs through prolonged or repeated exposure Pictogram(s) Precautionary Statement(s) P201 Obtain special instructions bef ore use. P202 Do not handle until all saf ety precautions have been read and understood. P264 Wash hands thoroughly af ter handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/protective clothing/eye protection/f ace protection. P308+P313 IF exposed or concerned Get medical advice/attention. P405 Store locked up. P501 Dispose of contents/container to an approved waste disposal plant. Hazards Not Otherwise Classified Not classif ied. Ingredient(s) with Unknown Toxicity No data available Section 3: Composition/Information on Ingredients Chemical Name Mometasone Furoate. Pregna-1,4-diene-3,20-dione, 9,21-dichloro-17-[(2-f uranylcarbonyl)oxy]-11-hydroxy-16-methyl-, (11beta, 16alpha)- Common Name Mometasone Furoate CAS Number 83919-23-7 Impurities and/or Stabilizing Additives No data available Section 4: First Aid Measures General Advice Remove from exposure. Remove contaminated clothing. For treatment advice, seek guidance from an occupational health physician or other licensed health-care provider f amiliar with workplace chemical exposures. In the United States, the national poison control center phone number is 1-800-222-1222. If person is not breathing, give artif icial respiration. If breathing is dif f icult, give oxygen if available. Persons developing serious hypersensitivity (anaphylactic) reactions must receive immediate medical attention. If Inhaled If breathing is dif f icult, remove to fresh air and keep at rest in a position comf ortable f or breathing. Call a physician if symptoms develop or persist. In Case of Skin Contact Rinse skin with water/shower. Get medical attention if irritation develops and persists. In Case of Eye Contact Rinse with water. Get medical attention if irritation develops and persists. If Swallowed Rinse mouth. If ingestion of a large amount does occur, call a poison control center immediately. Most Important Symptoms and Effects Not available. Indication of immediate medical attention and special treatment needed Acute toxicity f ollowing overdose is uncommon. Gastrointestinal decontamination is generally not necessary. Treatment should be symptomatic and supportive. [Poisindex 2010] Page 1 of 5 Section 5: Fire Fighting Measures Suitable Extinguishing Media Water spray, dry chemical, carbon dioxide, or f oam as appropriate f or surrounding f ire and materials. Special Hazards Arising From the Substance/Mixture No unusual f ire or explosion hazards noted. Special PPE and/or Precautions for Firefighters Wear suitable protective equipment. As with all f ires, evacuate personnel to a saf e area. Firef ighters should use selfcontained breathing equipment and protective clothing. Specif ic methods Cool containers exposed to f lames with water until well af ter the f ire is out. Section 6: Accidental Release Measures Personal Precautions, Protective Equipment and Emergency Procedures Keep unnecessary personnel away. Do not touch damaged containers or spilled material unless wearing appropriate protective clothing. Avoid inhalation of dust from the spilled material. Ensure adequate ventilation. Wear appropriate personal protective equipment. Methods and Materials Used for Containment Sweep up or vacuum up spillage and collect in suitable container f or disposal. Avoid the generation of dusts during clean-up. For waste disposal, see section 13 of the SDS. Wash spill site. Cleanup Procedures Sweep up or vacuum up spillage and collect in suitable container f or disposal. Avoid the generation of dusts during clean-up. For waste disposal, see section 13 of the SDS. Wash spill site. Section 7: Handling and Storage Precautions for Safe Handling Avoid all contact and inhalation of dust, mists, and/or vapors associated with the material. Clean equipment and work surf aces with suitable detergent or solvent af ter use. Af ter removing gloves, wash hands and other exposed skin thoroughly. Conditions for Safe Storage Store in tight container as def ined in the USP-NF. This material should be handled and stored per label instructions to ensure product integrity. Section 8: Exposure Controls/Personal Protection Components with Workplace Control Parameters Biological limit values No biological exposure limits noted f or the ingredient(s). Exposure guidelines No exposure standards allocated. Appropriate Engineering Controls Airborne exposure should be controlled primarily by engineering controls such as general dilution ventilation, local exhaust ventilation, or process enclosure. Local exhaust ventilation is generally pref erred to general exhaust because it can control the contaminant at its source, preventing dispersion into the work area. An industrial hygiene survey involving air monitoring may be used to determine the ef f ectiveness of engineering controls. Ef f ectiveness of engineering controls intended f or use with highly potent materials should be assessed by use of nontoxic surrogate materials. Avoid any open handling of this material, particularly f or grinding, crushing, weighing, or other dustgenerating or aerosol-generating procedures. Use a laboratory f ume hood, vented enclosure, glovebox, or other ef f ective containment. Handle in accordance with good industrial hygiene and saf ety practice. PPE - Eye/Face Protection Saf ety glasses with sideshields are recommended. Face shields or goggles may be required if splash potential exists or if corrosive materials are present. Approved eye protection (e.g., bearing the ANSI Z87 or CSA stamp) is pref erred. Maintain eyewash f acilities in the work area. PPE - Skin Protection Chemically compatible gloves. For handling solutions, ensure that the glove material is protective against the solvent being used. Use handling practices that minimize direct hand contact. Employees who are sensitive to natural rubber (latex) should use nitrile or other synthetic nonlatex gloves. Use of powdered latex gloves should be avoided due to the risk of latex allergy. This material is extremely potent. To reduce the risk of contamination of skin and surf aces, wear two pairs of gloves. Remove the outer gloves af ter handling and cleanup of the material, and remove the inner gloves only af ter removing other personal protective equipment. PPE - Body Protection For handling of laboratory scale quantities, a cloth lab coat is recommended. Where signif icant quantities are handled, work clothing may be necessary to prevent take-home contamination. PPE - Respiratory Protection Where respirators are deemed necessary to reduce or control occupational exposures, use NIOSH-approved respiratory protection and have an ef f ective respirator program in place (applicable U.S. regulation OSHA 29 CFR 1910.134). Page 2 of 5 Section 9: Physical and Chemical Properties Appearance White to of f-white clumpy powder. Upper/Lower Flammability or Explosive Limits Not available Odor Not available Vapor Pressure Not available Odor Threshold Not available Vapor Density Not available pH Not available Relative Density Not available Melting Point/Freezing Point 419 - 442.4 �F (215 - 228 �C) Solubility Solubility in water Insoluble. Solubility (other) Very soluble in ethanol; soluble in acetone, in dichloromethane, in dioxane, and in methanol; slightly soluble in octanol. Initial Boiling Point and Boiling Range Not available. Flash Point Not available. Evaporation Rate Not available. Flammability (Solid, Gas) Not applicable. Partition Coefficient 4.115 Auto-Ignition Temperature Not available. Decomposition Temperature Not available. Viscosity Not available. Section 10: Stability and Reactivity Reactivity No reactivity hazards known. Chemical Stability Stable at normal conditions. Possibility of Hazardous Reactions No dangerous reaction known under conditions of normal use. Conditions to Avoid None known. Incompatible Materials Strong oxidizers. Hazardous Decomposition Products Cl-. Irritating and/or toxic f umes or gases. Emits toxic f umes under f ire conditions. Page 3 of 5 Section 11: Toxicological Information Acute Toxicity - LD50 Oral LD50 Rat Oral > 2000 mg/kg Acute Toxicity - Inhalation Due to lack of data the classif ication is not possible. Acute Toxicity - Dermal Based on available data, the classif ication criteria are not met. Acute Toxicity - Eye Based on available data, the classif ication criteria are not met. Skin Corrosion/Irritation Based on available data, the classif ication criteria are not met. Serious Eye Damage/Irritation Based on available data, the classif ication criteria are not met. Respiratory or Skin Sensitazation Due to lack of data the classif ication is not possible. Germ Cell Mutagenicity Based on available data, the classif ication criteria are not met. Mutagenicity Ames test Result: Negative In vitro chromosomal aberration assay in Chinese hamster lung cells Result: Negative In vitro chromosomal aberration assay in Chinese hamster ovary cells Result: Positive In vivo mouse micronucleus assay Result: Negative In vivo unscheduled DNA synthesis assay in rat hepatocytes Result: Negative Mouse lymphoma assay Result: Negative Mouse male germcell chromosomal aberration assay Result: Negative Rat bone marrow chromosomal aberration assay Result: Negative Carcinogenicity IARC Based on available data, the classif ication criteria are not met. This product is not considered to be a carcinogen by IARC, ACGIH, NTP, or OSHA. Carcinogenicity ACGIH Based on available data, the classif ication criteria are not met. This product is not considered to be a carcinogen by IARC, ACGIH, NTP, or OSHA. Carcinogenicity NTP Based on available data, the classif ication criteria are not met. This product is not considered to be a carcinogen by IARC, ACGIH, NTP, or OSHA. Carcinogenicity OSHA Based on available data, the classif ication criteria are not met. This product is not considered to be a carcinogen by IARC, ACGIH, NTP, or OSHA. Reproductive Toxicity Suspected of damaging f ertility or the unborn child. Most studies have concluded that therapeutic use of corticosteroids by pregnant women does not cause adverse ef f ects on the f etus. A small increase in the incidence of clef t palate was seen in some human studies. Inf ants born to mothers who received substantial doses of corticosteroids during pregnancy should be observed f or signs of hypoadrenalism. Corticosteroids have been shown to cause birth def ects in laboratory animals when administered systemically at low doses, and some caused birth def ects when administered topically. Specific Target Organ Toxicity - Single Exposure Based on available data, the classif ication criteria are not met. Specific Target Organ Toxicity - Repeated Exposure Causes damage to organs (endocrine system) through prolonged or repeated exposure. Aspiration Hazard Based on available data, the classif ication criteria are not met. Section 12: Ecological Information Toxicity There are no data on the ecotoxicity of this product. Persistence and Degradability No data is available on the degradability of this product. Bio-accumulative Potential Not available. Mobility in Soil Not available. Other Adverse Effects Not available. Section 13: Disposal Considerations Waste Treatment Methods Product This product, in its present state, when discarded or disposed of , is not a hazardous waste according to Federal regulations (40 CFR 261.4 (b)(4)). Under RCRA, it is the responsibility of the user of the product to determine, at the time of disposal, whether the product meets RCRA criteria f or hazardous waste. Dispose in accordance with all applicable regulations. Waste Treatment Methods Packaging Empty containers or liners may retain some product residues. This material and its container must be disposed of in a saf e manner (see: Disposal instructions). Contaminated packaging Empty containers should be taken to an approved waste handling site f or recycling or disposal. Since emptied containers may retain product residue, f ollow label warnings even af ter container is emptied. Special Precautions Landfill or Incinerations No data available Other Information No data available Section 14: Transport Information UN Number Not dangerous goods. UN Proper Shipping Name N/A Transport Hazard Class(es) N/A Packaging Group N/A Environmental Hazards No data available Page 4 of 5 Section 15: Regulatory Information US f ederal regulations CERCLA/SARA Hazardous Substances - Not applicable. One or more components are not listed on TSCA. Superf und Amendments and Reauthorization Act of 1986 (SARA) Hazard categories Immediate Hazard - No Delayed Hazard - No Fire Hazard - No Pressure Hazard - No Reactivity Hazard - No SARA 302 Extremely hazardous substance No SARA 311/312 Hazardous chemical No Other f ederal regulations Saf e Drinking Water Act (SDWA) Not regulated. Food and Drug Administration (FDA) Not regulated. US state regulations Calif ornia Saf e Drinking Water and Toxic Enf orcement Act of 1986 (Proposition 65): This material is not known to contain any chemicals currently listed as carcinogens or reproductive toxins. International Inventories Country(s) or region Inventory name On inventory (yes/no)* Australia Australian Inventory of Chemical Substances (AICS) No Canada Domestic Substances List (DSL) No Canada Non-Domestic Substances List (NDSL) No China Inventory of Existing Chemical Substances in China (IECSC) No Europe European Inventory of Existing Commercial Chemical No Substances (EINECS) Europe European List of Notif ied Chemical Substances (ELINCS) No Japan Inventory of Existing and New Chemical Substances (ENCS) No Korea Existing Chemicals List (ECL) No New Zealand New Zealand Inventory No Philippines Philippine Inventory of Chemicals and Chemical Substances No (PICCS) United States & Puerto Rico Toxic Substances Control Act (TSCA) Inventory No *A "Yes" indicates that all components of this product comply with the inventory requirements administered by the governing country(s) Section 16: Other Information Additional Information Inf ormation on likely routes of exposure Ingestion Based on available data, the classif ication criteria are not met. Inhalation Due to lack of data the classif ication is not possible. Skin contact Based on available data, the classif ication criteria are not met. Eye contact Based on available data, the classif ication criteria are not met. Symptoms related to the physical, chemical, and toxicological characteristics Mineralocorticoid ef f ects: Swelling. Conf usion. Lightheadedness. Nausea. Vomiting. Numbness. Tremors. Glucocorticoid ef f ects: Bone fractures. Back pain. Joint pain or stif f ness. Weakness. Increased appetite. Inf ection. Delayed wound healing. Thinning skin. Bruising. Purple lines on skin. Increased hair growth. Acne. Redistribution of body f at. Menstrual irregularities. Impotence. Headache. Increased sweating. Eye pain. Change in vision. Mental or behavioral changes. Withdrawal ef f ects: Fever. Muscle pain. Joint pain. Malaise. Delayed and immediate ef f ects of exposure Corticosteroids: Fluid and electrolyte imbalance. Cushing's syndrome. Adrenal suppression. Immune system depression. Withdrawal. Cross sensitivity Persons sensitive to one corticosteroid may be sensitive to this material also. Medical conditions aggravated by exposure Corticosteroids: Heart disease. High blood pressure. Diabetes. Epilepsy. Glaucoma. Hypothyroidism. Osteoporosis. Peptic ulcer. Systemic f ungal inf ection. Mental disorders. Impaired liver or kidney f unction. Acute toxicity Based on available data, the classif ication criteria are not met. Prepared By Lisa Russell Revision Date 01/03/2019 15:56 Disclaimer Letco Medical, LLC believes that the above information is correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. If the product is used as a component in another product, this information may not be applicable. NO WARRANTY OF FITNESS FOR ANY PARTICULAR PURPOSE, WARRANTY OF MERCHANTABILITY OR ANY OTHER WARRANTY, EXPRESSED OR IMPLIED, IS MADE CONCERNING THE INFORMATION PROVIDED ABOVE. Letco Medical shall not be held liable for any loss or damage resulting from handling, storage, use or from contact with the above product. Page 5 of 5
